12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks experienced significant movements. NGM Biopharmaceuticals (NGM) saw an 11.5% increase, while TC BioPharm (TCBP) rose by 11.24%. Nemaura Medical (NMRD), Exagen (XGN), NanoVibronix (NAOV), and Allarity Therapeutics (ALLR) also posted gains. Conversely, Alzamend Neuro (ALZN) dropped by 19.4%, Gain Therapeutics (GANX) fell by 16.37%, Acutus Medical (AFIB) declined by 16.04%, AVITA Medical (RCEL) decreased by 11.2%, Vicarious Surgical (RBOT) went down by 10.67%, and Forte Biosciences (FBRX) fell by 9.77%.
November 20, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NGM Biopharmaceuticals stock rose by 11.5% to $0.7 with a trading volume of 109.4K shares.
The significant after-market gain on a volume that is a substantial percentage of the average volume suggests positive investor sentiment, which could lead to short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
TC BioPharm stock increased by 11.24% to $0.58, with trading volume reaching 265.9K shares.
The stock's rise on a trading volume significantly higher than the average may indicate strong investor interest, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Alzamend Neuro shares decreased by 19.4% to $1.12, with a trading volume of 2.7 million shares.
The substantial drop in price accompanied by an exceptionally high trading volume indicates negative market sentiment, which could lead to further short-term decline.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Gain Therapeutics shares fell 16.37% to $2.3, with the market cap at $29.2 million.
The significant after-market drop could reflect investor reactions to recent earnings or other company-specific news, suggesting a negative short-term outlook.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90